Author name: TB Alliance

An alliance of tuberculosis researchers is partnering with Bayer AG of Germany to conduct the first major clinical trial program

JOHANNESBURG, South Africa – A new therapy for treating tuberculosis could cut the current six-month treatment time in half, expand

Anyone who has struggled with Eurostar’s internet booking service, braved the Northern line to get to Waterloo and weaved through

On September 8, 2005 the European Parliament passed a resolution calling for commitment and funding for innovation to fight TB

In June 2005, the TB Alliance approached Abbott and was granted the rights to develop a class of quinolones that

When Scott Franzblau began researching tuberculosis in the early 1990s, he had a hunch that the clarithromycin related macrolides he

A study released by the London School of Economics credits public-private partnerships (PPPs), such as the TB Alliance, for the

Stronger incentives to smaller biomedical companies rather than to large pharmaceutical groups could help boost the development of treatments for

New hope in developing drugs for the poor “BIG pharmaceuticals…right up there with the arms dealers,” says a character in

Dr. Mdluli joined the TB Alliance R&D team in May as the Project Leader of Research, working closely with Dr.